Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 1, 1997, Pages 85-88

  Dockhorn, Robert J ^a   Wagner, Daniel E ^a   Burgess, Gina L ^a   Hafner, Kerry B ^a   Letourneau, Kent ^a   Colice, Gene L ^b   Klinger, Nancy M ^b  

^a IMTCI   (United States)

^b 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROVENTIL HFA; SALBUTAMOL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; METERED DOSE INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0030877120     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63091-8     Document Type: Article

References (17)

1. Molina JM, Rowland FS. Stratospheric sink for chlorofluoromethanes: Chlorine atom catalysed destruction of ozone. Nature 1974;249:810-2.
2. Environmental effects of ozone depletion: 1991 update. Panel Report pursuant to Article 6 of the Montreal Protocol on Substances that Deplete the Ozone layer under the auspices of the United Nations Environment Programme. J Photochem Photobiol B. 1992;13:187-90.
3. D'Souza S. The Montreal Protocol and essential use exemptions. J Aerosol Med 1995;8(sup 1):13-7.
4. Donnell D, Harrison LI, Ward S, et al. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler. Eur J Clin Pharmacol. 1995;48:671-82.
5. Kleerup EC, Tashkin DP, Cline AC, Ekholm BP. Cumulative dose-response study of non-CFC propellant HFA-134a salbutamol sulfate metered-dose inhaler in patients with asthma. Chest 1996;109:702-7.
6. Dockhorn R, Vanden Burgt JA, Ekholm BP, et al. Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metereddose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma. J Allergy Clin Immunol 1995; 96:50-6.
7. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987;136:1285-98.
8. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
9. Anderson S, Scale JP, Ferris L, et al. An evaluation of pharmacotherapy for exercise-induced asthma. J Allergy Clin Immunol 1979;64:612-24.
10. Johnson CE, Belfield PW, Davis S, et al. Platelet activation during exercise induced asthma: effect of prophylaxis with cromoglycate and salbutamol. Thorax 1986;41:290-4.
11. Boulet L-P, Turcotte H, Tennina S. Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges. J Allergy Clin Immunol 1989; 83:882-7.
12. Ibanez MD, Laso MT, Alonso E, et al. Effect of theophylline on airway responsiveness to methacholine and on exercise-induced bronchoconstrictio Ann Allergy 1994;73:357-63.
13. Inman MD, O'Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med 1996;153: 65-9.
14. Eggleston PA, Guerrant JL. A standardized method of evaluating exercise-induced asthma. J Allergy Clin Immunol 1976;58:414-25.
15. Eggleston PA, Rosenthal RR, Anderson S, et al. Guidelines for the methodology of exercise challenge testing of asthmatics. J Allergy Clin Immunol 1979;64:642-5.
16. Anderson S. Exercise-induced asthma. In Middleton E, Jr., Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds: Allergy: Principles and Practice, St. Louis, MO, Mosby, 1993, pp 1343-1367.
17. Freeman W, Packe GE, Cayton RM. Effect of nebulised salbutamol on maximal exercise performance in men with mild asthma. Thorax 1989;44: 942-7.